Back to Search
Start Over
1119 - FIERCE-21: Phase 2 study of vofatamab (B-701), a selective inhibitor of FGFR3, as salvage therapy in metastatic urothelial carcinoma (mUCC).
- Source :
-
European Urology Supplements . Mar2019, Vol. 18 Issue 1, pe1513-e1513. 1p. - Publication Year :
- 2019
- Subjects :
- *SALVAGE therapy
*CARCINOMA
Subjects
Details
- Language :
- English
- ISSN :
- 15699056
- Volume :
- 18
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- European Urology Supplements
- Publication Type :
- Academic Journal
- Accession number :
- 135600691
- Full Text :
- https://doi.org/10.1016/S1569-9056(19)31090-5